GB0317592D0 - Method - Google Patents
MethodInfo
- Publication number
- GB0317592D0 GB0317592D0 GBGB0317592.4A GB0317592A GB0317592D0 GB 0317592 D0 GB0317592 D0 GB 0317592D0 GB 0317592 A GB0317592 A GB 0317592A GB 0317592 D0 GB0317592 D0 GB 0317592D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- oatp
- polymorphisms
- pharmacokinetics
- relates
- statin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 3
- 101000836291 Homo sapiens Solute carrier organic anion transporter family member 1B1 Proteins 0.000 abstract 3
- 102100027233 Solute carrier organic anion transporter family member 1B1 Human genes 0.000 abstract 2
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract 2
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 abstract 2
- 229960000672 rosuvastatin Drugs 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 102000057538 human SLCO1B1 Human genes 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Semiconductor Lasers (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317592.4A GB0317592D0 (en) | 2003-07-26 | 2003-07-26 | Method |
| US10/566,054 US7700277B2 (en) | 2003-07-26 | 2004-07-26 | Use of polymorphisms in human OATP-C associated with an effect on statin pharmacokinetics in humans in statin therapy |
| AT04743565T ATE373730T1 (de) | 2003-07-26 | 2004-07-26 | Verwendung von humanen oatp-c polymorphismen, die einen effekt auf die pharmakokinetik von statin haben, bei der statin-therapie |
| PL04743565T PL1651774T3 (pl) | 2003-07-26 | 2004-07-26 | Zastosowanie palimorfizmów ludzkiego OATP-C związanych z wpływem na farmakokinetykę statyn u ludzi leczonych statynami |
| PT04743565T PT1651774E (pt) | 2003-07-26 | 2004-07-26 | Utilização de polimorfismos na oatp-c humana, associados com um efeito sobre a farmacocinética da estatina, em humanos em terapia com estatina |
| DK04743565T DK1651774T3 (da) | 2003-07-26 | 2004-07-26 | Anvendelse af polymorfier i humant OATP-C forbundet med en virkning på statinfarmakinetik i mennesker under statinterapi |
| PCT/GB2004/003236 WO2005012566A2 (en) | 2003-07-26 | 2004-07-26 | Use of polymorphisis in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
| EP04743565A EP1651774B1 (en) | 2003-07-26 | 2004-07-26 | Use of polymorphisms in human oatp-c associated with an effect on statin pharmacokinetics in humans in statin therapy |
| ES04743565T ES2291899T3 (es) | 2003-07-26 | 2004-07-26 | Uso de polmorfismos en oatp-c humano asociados con un efecto sobre la farmacocinetica de la estatina en seres humanos en terapia que usa estatina. |
| SI200430494T SI1651774T1 (sl) | 2003-07-26 | 2004-07-26 | Uporaba polimorfizmov v cloveskem OATP-C, povezanih z ucinkom na farmakokinetiko statina pri ljudehs statinsko terapijo |
| JP2006521655A JP4166257B2 (ja) | 2003-07-26 | 2004-07-26 | ヒトにおけるスタチン薬物動態に対する効果と関連するヒトｏａｔｐ−ｃにおける多型のスタチン療法での使用 |
| DE602004009083T DE602004009083T2 (de) | 2003-07-26 | 2004-07-26 | Verwendung von humanen oatp-c polymorphismen, die einen effekt auf die pharmakokinetik von statin haben, bei der statin-therapie |
| CY20071101470T CY1107801T1 (el) | 2003-07-26 | 2007-11-14 | Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινης |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0317592.4A GB0317592D0 (en) | 2003-07-26 | 2003-07-26 | Method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0317592D0 true GB0317592D0 (en) | 2003-08-27 |
Family
ID=27772801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0317592.4A Ceased GB0317592D0 (en) | 2003-07-26 | 2003-07-26 | Method |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7700277B2 (enExample) |
| EP (1) | EP1651774B1 (enExample) |
| JP (1) | JP4166257B2 (enExample) |
| AT (1) | ATE373730T1 (enExample) |
| CY (1) | CY1107801T1 (enExample) |
| DE (1) | DE602004009083T2 (enExample) |
| DK (1) | DK1651774T3 (enExample) |
| ES (1) | ES2291899T3 (enExample) |
| GB (1) | GB0317592D0 (enExample) |
| PL (1) | PL1651774T3 (enExample) |
| PT (1) | PT1651774E (enExample) |
| WO (1) | WO2005012566A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1784504A2 (en) * | 2004-07-21 | 2007-05-16 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Oatp-c gene c463a polymorphism underlies variable response of statin therapy |
| CN102016073A (zh) | 2008-02-29 | 2011-04-13 | Isis创新有限公司 | 诊断方法 |
| US9817001B2 (en) | 2008-05-27 | 2017-11-14 | Boston Heart Diagnostics Corporation | Methods for determining LDL cholesterol treatment |
| US8470541B1 (en) | 2008-09-27 | 2013-06-25 | Boston Heart Diagnostics Corporation | Methods for separation and immuno-detection of biomolecules, and apparatus related thereto |
| WO2013056087A2 (en) * | 2011-10-13 | 2013-04-18 | Boston Heart Diagnostics | Compositions and methods for treating and preventing coronary heart disease |
| US9828624B2 (en) | 2013-07-24 | 2017-11-28 | Boston Heart Diagnostics Corporation | Driving patient compliance with therapy |
| EP3220810A4 (en) | 2014-11-17 | 2018-05-16 | Boston Heart Diagnostic Corporation | Cardiovascular disease risk assessment |
| US10572811B2 (en) | 2015-01-29 | 2020-02-25 | Splunk Inc. | Methods and systems for determining probabilities of occurrence for events and determining anomalous events |
| CA3100035A1 (en) | 2018-08-27 | 2020-03-05 | Regeneron Pharmaceuticals, Inc. | Use of raman spectroscopy in downstream purification |
| CN110904215A (zh) * | 2019-12-16 | 2020-03-24 | 西安和合医学检验所有限公司 | 用于同步检测slco1b1基因的两个snp位点的基因多态性的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US32011A (en) * | 1861-04-09 | Coffee-pot | ||
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4411993A (en) | 1981-04-29 | 1983-10-25 | Steven Gillis | Hybridoma antibody which inhibits interleukin 2 activity |
| USRE32011E (en) | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
| US4543439A (en) | 1982-12-13 | 1985-09-24 | Massachusetts Institute Of Technology | Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
| US4902614A (en) | 1984-12-03 | 1990-02-20 | Teijin Limited | Monoclonal antibody to human protein C |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| GB8902689D0 (en) | 1989-02-07 | 1989-03-30 | Ici Plc | Assay method |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| CA2176348C (en) | 1993-11-12 | 2004-11-02 | Sanjay Tyagi | Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| WO2000008157A2 (en) | 1998-08-07 | 2000-02-17 | Axys Pharmaceuticals, Inc. | Human anion transporter genes atnov |
| US20020090622A1 (en) | 2000-08-23 | 2002-07-11 | Monisola Adeokun | Chemical compounds |
-
2003
- 2003-07-26 GB GBGB0317592.4A patent/GB0317592D0/en not_active Ceased
-
2004
- 2004-07-26 PL PL04743565T patent/PL1651774T3/pl unknown
- 2004-07-26 AT AT04743565T patent/ATE373730T1/de active
- 2004-07-26 US US10/566,054 patent/US7700277B2/en not_active Expired - Fee Related
- 2004-07-26 WO PCT/GB2004/003236 patent/WO2005012566A2/en not_active Ceased
- 2004-07-26 JP JP2006521655A patent/JP4166257B2/ja not_active Expired - Fee Related
- 2004-07-26 DK DK04743565T patent/DK1651774T3/da active
- 2004-07-26 ES ES04743565T patent/ES2291899T3/es not_active Expired - Lifetime
- 2004-07-26 EP EP04743565A patent/EP1651774B1/en not_active Expired - Lifetime
- 2004-07-26 DE DE602004009083T patent/DE602004009083T2/de not_active Expired - Lifetime
- 2004-07-26 PT PT04743565T patent/PT1651774E/pt unknown
-
2007
- 2007-11-14 CY CY20071101470T patent/CY1107801T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005012566A3 (en) | 2005-06-16 |
| US7700277B2 (en) | 2010-04-20 |
| WO2005012566A2 (en) | 2005-02-10 |
| EP1651774B1 (en) | 2007-09-19 |
| DE602004009083T2 (de) | 2008-06-19 |
| DE602004009083D1 (de) | 2007-10-31 |
| ATE373730T1 (de) | 2007-10-15 |
| EP1651774A2 (en) | 2006-05-03 |
| DK1651774T3 (da) | 2008-01-07 |
| ES2291899T3 (es) | 2008-03-01 |
| PL1651774T3 (pl) | 2007-12-31 |
| JP4166257B2 (ja) | 2008-10-15 |
| PT1651774E (pt) | 2007-11-16 |
| US20070031838A1 (en) | 2007-02-08 |
| JP2007500005A (ja) | 2007-01-11 |
| CY1107801T1 (el) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107801T1 (el) | Χρηση πολυμορφισμων στον ανθρωπινο oatp-c που σχετιζονται με μια επιδραση στη φαρμακοκινητικη στατινης σε ανθρωπους σε θεραπεια στατινης | |
| WO2004073623A3 (en) | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions | |
| WO2004010937A3 (en) | Method of treating cancer | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| WO2004004644A3 (en) | Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms | |
| WO2004030625A3 (en) | Synergistic methods and compositions for treating cancer | |
| EP1515724A4 (en) | MITOTIC KINESINE HEMMER | |
| IL180872A0 (en) | Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv | |
| MXPA05005398A (es) | Meta para terapia de deterioro cognitivo. | |
| ATE428411T1 (de) | Hdl-verstärkende kombinationstherapie-komplexe | |
| CY1111565T1 (el) | Θεραπεια συνδυασμου του zd6474 με 5-fu και/ή cpt-11 | |
| WO2003101444A8 (en) | Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer | |
| TW200518769A (en) | Use of calcitonin in osteoarthritis | |
| WO2005016883A3 (en) | Acrylamide derivatives as vla-1 integrin antagonists and uses thereof | |
| NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
| WO2006002437A3 (en) | Treatment of conditions involving demyelination | |
| ATE549024T1 (de) | Chinazolin-kaliumkanalhemmer | |
| WO2004033666A3 (en) | Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| WO2005013911A3 (en) | Protective and therapeutic uses for tocotrienols | |
| WO2007047608A3 (en) | Fibrin targeted therapeutics | |
| WO2005047478A3 (en) | Compositions and methods for regulation of tumor necrosis factor-alpha | |
| SE0301654D0 (sv) | Novel compounds | |
| WO2005011611A3 (en) | Bicyclic compounds and compositions as pdf inhibitors | |
| UA85187C2 (en) | 2-aminobenzoyl derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |